by Clinical Neuropsychologist Online | Tuesday, August 25, 2026 | Paediatric Neuropsychology
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | August 25, 2026 Neuro-Paediatric Previous Page
by Clinical Neuropsychologist Online | Tuesday, August 25, 2026 | Dementia
Abstract BACKGROUND Polypharmacy, potentially inappropriate medications (PIMs), and drugs associated with drug-induced cognitive impairment (DICI) are highly prevalent in older adults and may affect cognitive decline. METHODS This observational retrospective study...
by Clinical Neuropsychologist Online | Tuesday, August 25, 2026 | Paediatric Neuropsychology
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | August 25, 2026 Neuro-Paediatric Previous Page
by Clinical Neuropsychologist Online | Tuesday, August 25, 2026 | Dementia
Abstract BACKGROUND Vascular and glymphatic dysfunction are increasingly implicated in Alzheimer’s disease (AD), particularly among apolipoprotein E (APOE) ε4 carriers. We investigated relationships among retinal microvasculature, glymphatic markers, and AD...
by Clinical Neuropsychologist Online | Tuesday, August 25, 2026 | Dementia
Abstract INTRODUCTION Cerebral amyloid angiopathy (CAA) is a leading cause of lobar intracerebral hemorrhage (ICH) in the elderly. The influence of apolipoprotein E (APOE) variants, CAA pathology, and concomitant Alzheimer’s disease (AD) neuropathologic changes...
